Francesco Rossi
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions 8
- Pharmacology top 5%
- Drug-Induced Adverse Reactions 5
-
- Diabetes Treatment and Management 6
- Geriatrics and Gerontology top 10%
- Oncology top 10%
-
- Pharmaceutical studies and practices 13
-
- Synthesis and biological activity 6
- Synthesis and Reactions of Organic Compounds 6
-
- Neuropeptides and Animal Physiology 5
-
- Prostate Cancer Diagnosis and Treatment 5
- Co-authors
- Annalisa CapuanoGiuseppe PaolissoConcetta RafanielloMichele D’AmicoCristina ScavoneAnnamaria MascoloS DragoniLiberata Sportiello
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)Diabetes (1 paper)
- Partner nations
- ItalyUnited StatesDenmark
In The Last Decade
Francesco Rossi
103 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 132
- Toxicology 146
- Pharmacology 287
- Endocrinology, Diabetes and Metabolism 219
- Geriatrics and Gerontology 51
- Oncology 266
Countries citing papers authored by Francesco Rossi
This map shows the geographic impact of Francesco Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Rossi more than expected).
Fields of papers citing papers by Francesco Rossi
This network shows the impact of papers produced by Francesco Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Rossi. The network helps show where Francesco Rossi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francesco Rossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 13 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 15 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 33 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 14 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 2 | |
| 13 | 2018 | 10 | |
| 14 | Incretin-based therapies and cancer risk: a review of recent literature safety data | 2016 | 2 |
| 15 | 2015 | 3 | |
| 16 | 2012 | 27 | |
| 17 | [Hypersensitivity reactions to chemotherapeutic antineoplastic agents]. | 2004 | 10 |
| 18 | 1995 | 6 | |
| 19 | 1994 | 3 | |
| 20 | La previdenza sociale | 1980 | 0 |
About Francesco Rossi
Francesco Rossi is a scholar working on Toxicology, Applied Microbiology and Biotechnology and Geriatrics and Gerontology, having authored 112 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (13 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers), Synthesis and biological activity (6 papers), Diabetes Treatment and Management (6 papers), Synthesis and Reactions of Organic Compounds (6 papers), Neuropeptides and Animal Physiology (5 papers), Drug-Induced Adverse Reactions (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Toxicology (146 citations), Pharmacology (287 citations) and Endocrinology, Diabetes and Metabolism (219 citations). Francesco Rossi has collaborated with scholars based in Italy, United States and Denmark. Frequent co-authors include Annalisa Capuano, Giuseppe Paolisso, Concetta Rafaniello, Michele D’Amico, Cristina Scavone, Annamaria Mascolo, S Dragoni, Liberata Sportiello, Raffaele Marfella and Francesca Rossi. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.